The DOI matches its Crossref record; 247 of the 247 references it cites were found in a registry or an index.
Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing
Open accessAbstract
Cervical cancer is the fourth most frequently occurring cancer in women around the world and can affect them during their reproductive years. Since the development of the Papanicolaou (Pap) test, screening has been essential in identifying cervical cancer at a treatable stage. With the identification of the human papillomavirus (HPV) as the causative agent of essentially all cervical cancer cases, HPV molecular screening tests and HPV vaccines for primary prevention against the virus have been developed. Accordingly, comparative studies were designed to assess the performance of cervical cancer screening methods in order to devise the best screening strategy possible. This review critically assesses the current cervical cancer screening methods as well as the implementation of HPV vaccination in Europe. The most recent European Guidelines and recommendations for organized population-based programs with HPV testing as the primary screening method are also presented. Lastly, the current landscape of cervical cancer screening programs is assessed for both European Union member states and some associated countries, in regard to the transition towards population-based screening programs with primary HPV testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–247 of 247
Cervical cancer screening by simple visual inspection after acetic acid
Belinson, J. L. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01738-0 · Cited by 19
HPV primary cervical screening: time for a change
Kitchener, H. C. (2015) · Cytopathology · doi:10.1111/cyt.12236 · Cited by 18
hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy
Carozzi, F., Visioli, C. B., Confortini, M., Iossa, A., Mantellini, P., Burroni, E., & Zappa, M. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.519 · Cited by 18
Trapero‐Bertran, M., Pérez, A. A., de Sanjosé, S., Manresa‐Domínguez, J. M., Capriles, D. R., Martinez, A. R., Bonet, J. M., Sànchez, N., Valls, P. H., & Díaz, M. (2017) · BMC Public Health · doi:10.1186/s12889-017-4115-0 · Cited by 18
Kristiansen, B. K., Andersen, B. S., Bro, F., Svanholm, H., & Vedsted, P. (2017) · British Journal of General Practice · doi:10.3399/bjgp17x691913 · Cited by 18
Farazi, P. A. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2014.389 · Cited by 16
Šubelj, M., Učakar, V., Kraigher, A., & Klavs, I. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.14.30187 · Cited by 16
Chatzistamatiou, Κ., Chatzaki, Ε., Constantinidis, Τ., Nena, E., Tsertanidou, A., & Αγοραστός, Θ. (2017) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2017.1323197 · Cited by 16
Paul, K. T., Wallenburg, I., & Bal, R. A. (2017) · Sociology of Health & Illness · doi:10.1111/1467-9566.12595 · Cited by 16
Machado, J. F., Mendes, R., Moreira, A., & Lunet, N. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017730 · Cited by 16
Breitenecker, G., Dinges, H. P., Regitnig, P., Wiener, H., & Vutuc, C. (2004) · Cytopathology · doi:10.1111/j.1365-2303.2004.00125.x · Cited by 15
Role of HPV testing in the follow-up of women treated for cervical dysplasia
Ribaldone, R., Boldorini, R. L., Capuano, A., Arrigoni, S., Oto, A. D., & Surico, N. (2009) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-009-1316-5 · Cited by 15
Tamalet, C., Halfon, P., Retraite, L. L., Grob, A., Léandri, F.-X., Heid, P., Sancho-Garnier, H., & Piana, L. (2016) · Journal of Clinical Virology · doi:10.1016/j.jcv.2016.02.027 · Cited by 14
HPV-Type Distribution and Reproducibility of Histological Diagnosis in Cervical Neoplasia in Poland
Nowakowski, A. M., de Souza, S. C., Jach, R., Rosillon, D., Książek, A., & Holl, K. (2014) · Pathology & Oncology Research · doi:10.1007/s12253-014-9877-4 · Cited by 13
Disengagement of general practitioners in cervical cancer screening
Poncet, L., Rigal, L., Panjo, H., Gautier, A., Chauvin, P., Menvielle, G., Cadot, E., & Ringa, V. (2015) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000208 · Cited by 13
Alfonzo, E., Andersson‐Ellström, A., Nemes, S., & Strander, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150888 · Cited by 13
Borena, W., Grünberger, M., Widschwendter, A., Kraxner, K. H., Marth, E., Mayr, P., Meier, J., Ruth, N., Guerrero, A., Marth, C., et al. (2016) · BMC Public Health · doi:10.1186/s12889-016-3581-0 · Cited by 13
Burden of HPV-caused cancers in Denmark and the potential effect of HPV-vaccination
Skorstengaard, M., Thamsborg, L. H., & Lynge, E. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.08.062 · Cited by 13
Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing?
Coorevits, L., Traen, A., Bingé, L., Dorpe, J. V., Praet, M. M., Boelens, J., & Padalko, E. Y. (2017) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2018.29.e8 · Cited by 13
McCarthy, C., Ramphul, M., Madden, M., & Hickey, K. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.05.029 · Cited by 12
Loss of chance associated with sub-optimal HPV vaccination coverage rate in France
Uhart, M., Adam, M., Dahlab, A., & Bresse, X. (2017) · Papillomavirus Research · doi:10.1016/j.pvr.2017.02.004 · Cited by 12
Latsuzbaia, A., Hebette, G., Fischer, M., Arbyn, M., Weyers, S., Vielh, P. R., Schmitt, F. C., & Mossong, J. (2017) · Diagnostic Cytopathology · doi:10.1002/dc.23678 · Cited by 12
Cervical cancer screening in Latvia: a brief history and recent improvements (2009-2011).
Vīberga, I., & Poljak, M. (2013) · PubMed · Cited by 11
Rebolj, M., Njor, S. H., Lynge, E., Preisler, S., Ejegod, D. M., Rygaard, C., & Bonde, J. H. (2017) · Cytopathology · doi:10.1111/cyt.12451 · Cited by 11
Register-based studies of cancer screening effects
von Euler‐Chelpin, M., Lynge, E., & Rebolj, M. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811401479 · Cited by 10
Breitenecker, G. (2009) · Der Pathologe · doi:10.1007/s00292-009-1189-1 · Cited by 9
Májek, O., Duskova, J., Dvořák, V., Beková, A., Klimeš, D., Blaha, M., Anttila, A., & Dušek, L. (2016) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000236 · Cited by 9
Reasons for Non-appearance on Organized Cervical Screening in Hungary
Pakai, A., Brantmüller, É., Vajda, R., Karácsony, I., & Balázs, P. (2016) · Practice and theory in systems of education · doi:10.1515/ptse-2016-0015 · Cited by 9
Marek, E., Berényi, K., Dergez, T., Kiss, I., & D’Cruz, G. (2015) · European Journal of Cancer Care · doi:10.1111/ecc.12332 · Cited by 8
Quality of screening with conventional Pap smear in Austria – a longitudinal evaluation
Rásky, É., Regitnig, P., Schenouda, M., Burkert, N. T., & Freidl, W. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-998 · Cited by 8
Flannelly, G., Mooney, T., Greehy, G. M., Keogh, E. B., McNally, S. A., & Fitzpatrick, P. (2016) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000323 · Cited by 8
The prevalence of HPV infections in HPV ‐vaccinated women from the general population
Hamšíková, E., Šmahelová, J., Ludvíková, V., Saláková, M., Rychlá, J., Skrenková, J., Rob, L., & Tachezy, R. (2017) · Apmis · doi:10.1111/apm.12677 · Cited by 8
Recent trends of cervical cancer and Cervical Intraepithelial Neoplasia 3 (CIN3) in Israel
Bassal, R., Schejter, E., Bachar, R., Shapira, H., Kaufman, Z., Cohen, D., & Keinan‐Boker, L. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3655-8 · Cited by 7
Results of the Czech National Cervical Cancer Screening Programme
Duskova, J., Beková, A., Dvořák, V., Májek, O., & Dušek, L. (2014) · Klinicka onkologie · doi:10.14735/amko20142s79 · Cited by 7
Samson, K. K., Haynatzki, G. R., Soliman, A. S., & Valerianova, Z. (2016) · Cancer Epidemiology · doi:10.1016/j.canep.2016.08.014 · Cited by 7
The paradigm shift in cervical cancer screening in Germany
Hillemanns, P. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3940-6 · Cited by 6
Higgins, L. M., Dirksing, K., Ding, L., et al. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1150395 · Cited by 6
Kurtinaitienė, R., Rimienė, J., Labanauskaitė, I., Lipunova, N., & Smailytė, G. (2016) · Acta medica Lituanica · doi:10.6001/actamedica.v23i3.3383 · Cited by 6
Pista, Â., Oliveira, C., Lopes, C., Cunha, M. J., & the CLEOPATRE Portugal study group (2017) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12243 · Cited by 6
Prasaad, P. R. (2017) · Comparative Clinical Pathology · doi:10.1007/s00580-017-2524-1 · Cited by 5
Dilley, S. E., Miller, K., & Huh, W. K. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.11.037 · Cited by 5
Aktueller Stand der HPV-Impfung in Deutschland
Garbe, Y., & Klug, S. J. (2017) · Der Onkologe · doi:10.1007/s00761-017-0231-9 · Cited by 4
HPV Vaccinations in Lublin Region, Poland
Kalinowski, P., & Grządziel, A. (2017) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/01.3001.0010.3793 · Cited by 3
Cervical Screening: History, Current Algorithms, and Future Directions
Smith, J. H. F. (2017) · Springer eBooks · doi:10.1007/978-3-319-51257-0_3 · Cited by 3
Guenat, D., Launay, S., Riethmuller, D., Mougin, C., & Prétet, J. (2016) · Infectious Agents and Cancer · doi:10.1186/s13027-016-0092-7 · Cited by 2
Kır, G., Şeneldir, H., & Sarbay, B. C. (2017) · Diagnostic Cytopathology · doi:10.1002/dc.23836 · Cited by 2
The introduction of the HPV primary screening programme
Kothari, A. (2017) · Practice Nursing · doi:10.12968/pnur.2017.28.4.162 · Cited by 1
Metadata
- Authors
- Chrysostomou, A. C., Stylianou, D. C., Constantinidou, A., & Kostrikis, L. G.
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2018-12-19
- Volume
- 10
- Issue
- 12
- Pages
- 729
- ISSN
- 1999-4915 (ISSN-L)
- OpenAlex
- W2904344046
- Cited by
- 258
- References
- 247
- FWCI
- 16.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.